Quarterly report [Sections 13 or 15(d)]

LICENSES ACQUIRED (Details)

v3.26.1
LICENSES ACQUIRED (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended
Nov. 11, 2024
Jun. 29, 2021
Dec. 31, 2024
Apr. 30, 2024
Jan. 31, 2022
Mar. 31, 2021
Jul. 31, 2020
Mar. 31, 2026
Assets and Licenses Acquired                
Total other revenues               $ 40
Amzeeq                
Assets and Licenses Acquired                
Percentage of license         4.00%      
Zilxi                
Assets and Licenses Acquired                
Percentage of license         1.50%      
Emrosi Agreement                
Assets and Licenses Acquired                
Total Upfront payment   $ 10,000            
Upfront payment upon execution       $ 3,000        
Remaining upfront payment     $ 15,000          
Transformation of ownership and all assets of milestone payments   15,000            
Threshold additional contingent regulatory and commercial milestone payments payable   $ 150,000            
Percentage of reduction in royalty upon launching of competitor products   50.00%            
Emrosi Agreement | Minimum                
Assets and Licenses Acquired                
Percentage of royalties payable on net sales   10.00%            
Emrosi Agreement | Maximum                
Assets and Licenses Acquired                
Percentage of royalties payable on net sales   14.00%            
Asset purchase agreement | Qbrexza                
Assets and Licenses Acquired                
Age of patients           9 years    
Asset purchase agreement | Royalty payment percentage for first two years | Qbrexza                
Assets and Licenses Acquired                
Period of royalty payments           2 years    
Asset purchase agreement | Minimum | Royalty payment percentage for first two years | Qbrexza                
Assets and Licenses Acquired                
Percent of royalty payments           30.00%    
Asset purchase agreement | Minimum | Royalty payment percentage for thereafter | Qbrexza                
Assets and Licenses Acquired                
Percent of royalty payments           12.00%    
Asset purchase agreement | Maximum | Royalty payment percentage for first two years | Qbrexza                
Assets and Licenses Acquired                
Percent of royalty payments           40.00%    
Asset purchase agreement | Maximum | Royalty payment percentage for thereafter | Qbrexza                
Assets and Licenses Acquired                
Percent of royalty payments           19.00%    
Asset purchase agreement | Eli Lilly and Company | Qbrexza                
Assets and Licenses Acquired                
Upfront fees           $ 12,500    
Milestone payments payable           $ 144,000    
License and supply agreement With DRL | Accutane                
Assets and Licenses Acquired                
Amount of expense agreed to pay under the agreement             $ 5,000  
Contingent amount payable             $ 17,000  
Term of accutane             10 years  
Termination accutane agreement period             180 days  
Cutia License Agreement | Amzeeq                
Assets and Licenses Acquired                
Milestone payment $ 1,000              
Total other revenues $ 1,000             $ 40
VYNE APA                
Assets and Licenses Acquired                
Total Upfront payment         $ 450,000      
Upfront fees         20,000      
Upfront payment upon execution         5,000      
VYNE APA | Amzeeq | First year anniversary                
Assets and Licenses Acquired                
Net sales         100,000      
Amount of expense paid under the agreement         10,000      
VYNE APA | Amzeeq | Second year anniversary                
Assets and Licenses Acquired                
Net sales         200,000      
Amount of expense paid under the agreement         20,000      
VYNE APA | Amzeeq | Third year anniversary                
Assets and Licenses Acquired                
Net sales         300,000      
Amount of expense paid under the agreement         30,000      
VYNE APA | Amzeeq | Fourth year anniversary                
Assets and Licenses Acquired                
Net sales         400,000      
Amount of expense paid under the agreement         40,000      
VYNE APA | Amzeeq | Fifth year anniversary                
Assets and Licenses Acquired                
Net sales         500,000      
Amount of expense paid under the agreement         50,000      
VYNE APA | Zilxi | First year anniversary                
Assets and Licenses Acquired                
Net sales         100,000      
Amount of expense paid under the agreement         10,000      
VYNE APA | Zilxi | Second year anniversary                
Assets and Licenses Acquired                
Net sales         200,000      
Amount of expense paid under the agreement         20,000      
VYNE APA | Zilxi | Third year anniversary                
Assets and Licenses Acquired                
Net sales         300,000      
Amount of expense paid under the agreement         30,000      
VYNE APA | Zilxi | Fourth year anniversary                
Assets and Licenses Acquired                
Net sales         400,000      
Amount of expense paid under the agreement         40,000      
VYNE APA | Zilxi | Fifth year anniversary                
Assets and Licenses Acquired                
Net sales         500,000      
Amount of expense paid under the agreement         $ 50,000